✦ LIBER ✦

Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease

✍ Scribed by M. L. Friis; Ulla Grøn; N. -E. Larsen; H. Pakkenberg; E. F. Hvidberg

Publisher: Springer
Year: 1979
Tongue: English
Weight: 424 KB
Volume: 15
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00618517

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overcoming pharmacokinetic problems in t

Overcoming pharmacokinetic problems in the treatment of parkinson's disease

✍ Dr. J. A. Obeso; J. Vaamonde; F. Grandas; M. R. Luquin; M. Rodriguez; G. Lera; J 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 1023 KB

Daily fluctuations in movement capacity and dyskinesias are well recognized as the two major complications emerging after chronic levodopa treatment. Progressive loss of efficacy leading to severe disability and immobility is a very rare finding, most often reflecting pathological involvement beyond

Pharmacokinetic characteristics of agent

Pharmacokinetic characteristics of agents applied in the treatment of Parkinson’s disease

✍ Masahiro Nomoto; Masahiro Nagai; Akiko Nakatsuka; Noriko Nishikawa; Hayato Yabe; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 480 KB

Pharmacokinetic and Pharmacodynamic Chan

Pharmacokinetic and Pharmacodynamic Changes During the First Four Years of Levodopa Treatment in Parkinson’s Disease

✍ Phylinda L. S. Chan; John G. Nutt; Nicholas H. G. Holford 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 219 KB

Effect of age on the pharmacokinetics of

Effect of age on the pharmacokinetics of oral levodopa in patients with Parkinson's disease

✍ M. Contin; R. Riva; P. Martinelli; F. Albani; A. Baruzzi 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 436 KB

Treatment of Parkinson's disease: Disagr

Treatment of Parkinson's disease: Disagreements

✍ Michael Schulzer 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Medical treatment of Parkinson’s disease

✍ Stanlex Fahn 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 90 KB